Current Cardiology Reports最新文献_第2页

Transcatheter Myotomy for Hypertrophic Obstructive Cardiomyopathy. 经导管肌切开术治疗肥厚型梗阻性心肌病。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-10-19 DOI: 10.1007/s11886-024-02145-z

Barbara Danek, David Elison, Christine J Chung, James M McCabe

引用次数: 0

Artificial Intelligence Algorithms in Cardiovascular Medicine: An Attainable Promise to Improve Patient Outcomes or an Inaccessible Investment? 心血管医学中的人工智能算法：改善患者预后的可望而不可及的投资？

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-10-29 DOI: 10.1007/s11886-024-02146-y

Patrícia Bota, Geerthy Thambiraj, Sandeep C Bollepalli, Antonis A Armoundas

{"title":"Artificial Intelligence Algorithms in Cardiovascular Medicine: An Attainable Promise to Improve Patient Outcomes or an Inaccessible Investment?","authors":"Patrícia Bota, Geerthy Thambiraj, Sandeep C Bollepalli, Antonis A Armoundas","doi":"10.1007/s11886-024-02146-y","DOIUrl":"10.1007/s11886-024-02146-y","url":null,"abstract":"Purpose of review: This opinion paper highlights the advancements in artificial intelligence (AI) technology for cardiovascular disease (CVD), presents best practices and transformative impacts, and addresses current concerns that must be resolved for broader adoption.Recent findings: With the evolution of digitization in data collection, large amounts of data have become available, surpassing the human capacity for processing and analysis, thus enabling the application of AI. These models can learn complex spatial and temporal patterns from large amounts of data, providing patient-specific outputs. These advantages have resulted, at the moment, in more than 900 AI-based devices being approved, today, by regulatory entities, for clinical use, with similar to improved performance and efficiency compared to traditional technologies. However, issues such as model generalization, bias, transparency, interpretability, accountability, and data privacy remain significant barriers for broad adoption of these technologies. AI shows great promise in enhancing CVD care through more accurate and efficient approaches. Yet, widespread adoption is hindered by unresolved concerns of interested stakeholders. Addressing these challenges is crucial for fully integrating AI into clinical practice and shaping the future of CVD prevention, diagnosis and treatment.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1477-1485"},"PeriodicalIF":3.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142544252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Computational Medicine: What Electrophysiologists Should Know to Stay Ahead of the Curve. 计算医学：电生理学家保持领先地位须知》。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-09-20 DOI: 10.1007/s11886-024-02136-0

Matthew J Magoon, Babak Nazer, Nazem Akoum, Patrick M Boyle

{"title":"Computational Medicine: What Electrophysiologists Should Know to Stay Ahead of the Curve.","authors":"Matthew J Magoon, Babak Nazer, Nazem Akoum, Patrick M Boyle","doi":"10.1007/s11886-024-02136-0","DOIUrl":"10.1007/s11886-024-02136-0","url":null,"abstract":"Purpose of review: Technology drives the field of cardiac electrophysiology. Recent computational advances will bring exciting changes. To stay ahead of the curve, we recommend electrophysiologists develop a robust appreciation for novel computational techniques, including deterministic, statistical, and hybrid models.Recent findings: In clinical applications, deterministic models use biophysically detailed simulations to offer patient-specific insights. Statistical techniques like machine learning and artificial intelligence recognize patterns in data. Emerging clinical tools are exploring avenues to combine all the above methodologies. We review three ways that computational medicine will aid electrophysiologists by: (1) improving personalized risk assessments, (2) weighing treatment options, and (3) guiding ablation procedures. Leveraging clinical data that are often readily available, computational models will offer valuable insights to improve arrhythmia patient care. As emerging tools promote personalized medicine, physicians must continue to critically evaluate technology-driven tools they consider using to ensure their appropriate implementation.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1393-1403"},"PeriodicalIF":3.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cerebral Embolic Protection: Is There a Benefit for Left Atrial and Mitral Valve Procedures? 脑栓塞保护：左心房和二尖瓣手术是否有益？

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-10-07 DOI: 10.1007/s11886-024-02132-4

Besir Besir, Samir R Kapadia

{"title":"Cerebral Embolic Protection: Is There a Benefit for Left Atrial and Mitral Valve Procedures?","authors":"Besir Besir, Samir R Kapadia","doi":"10.1007/s11886-024-02132-4","DOIUrl":"10.1007/s11886-024-02132-4","url":null,"abstract":"Purpose of review: This review aims to highlight the current evidence on the use of cerebral embolic protection devices (CEPD) in left atrial and transcatheter mitral valve procedures. It also aims to summarize the antithrombotic management of patients undergoing such procedures.Recent findings: Ischemic stroke is one of the most devastating complications of structural heart procedures. The manifestation of periprocedural stroke can range from asymptomatic and detectable only through brain imaging to major stroke with neurological deficits. CEP devices were initially developed to mitigate the risk of stroke associated with transcatheter aortic valve replacement (TAVR). However, the efficacy of such devices during different cardiac interventions is yet to be fully demonstrated, especially in left atrial appendage closure (LAAO), and mitral valve interventions. Few studies demonstrated that the risk of periprocedural strokes after LAAO and mitral valve interventions is not negligible and is highest during the periprocedural period and then falls. The majority of patients undergoing those procedures have cerebral ischemic injuries detected on diffusion-weighted magnetic resonance imaging (DW-MRI). Moreover, a reasonable number of those patients had debris embolization on the filters of the CEPD. Pharmacological therapy with antithrombotic agents before, during, or after structural heart interventions is crucial and should be tailored to each patient's risk of bleeding and ischemia. Close monitoring that includes a full neurological assessment and frequent follow-up visits with cardiac echocardiography are important. The risk of periprocedural stroke in left atrial and transcatheter mitral valve procedures is not negligible. Pharmacological therapy with antithrombotic agents before, during, or after structural heart interventions is important to mitigate the risk of stroke, especially the long-term risk. More prospective studies are needed to assess the efficacy of CEPD in such procedures.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1341-1346"},"PeriodicalIF":3.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Good (Tumor Killing) and the Bad (Cardiovascular Complications) of Immunologic Checkpoint Inhibitors. 免疫检查点抑制剂的好处（杀死肿瘤）和坏处（心血管并发症）。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-10-23 DOI: 10.1007/s11886-024-02147-x

Maria T Gamero, Avish Patel, Eugene Storozynsky

{"title":"The Good (Tumor Killing) and the Bad (Cardiovascular Complications) of Immunologic Checkpoint Inhibitors.","authors":"Maria T Gamero, Avish Patel, Eugene Storozynsky","doi":"10.1007/s11886-024-02147-x","DOIUrl":"10.1007/s11886-024-02147-x","url":null,"abstract":"Purpose of review: This review details the significant advancement in knowledge of Immune-checkpoint inhibitor (ICI) and its potential deleterious cardiac immune-related adverse effects (irAE). We explore their mechanisms on the cardiac tissue, providing guidance on risk factors, clinical presentations, diagnostic strategies along with treatment.Recent findings: Recent findings have provided insights of cardiac irAEs that exist beyond the previously well-known ICI-induced myocarditis. We have a better understanding of the wide variety of cardiac irAEs pathologies both early and late onset. Moreover, there is more data on mechanisms of cardiotoxicity and patient and therapy-related risk factors, supporting closer routine cardiac monitoring with biomarkers and imaging for prevention and early detection. Diagnosing cardiac irAEs is a challenge given its broad clinical presentation. A high-level of suspicion in addition to early work-up is crucial to prevent serious cardiac events. A multi-disciplinary team including Cardiologists and Oncologists is essential for closely monitor patients' cardiac status on ICI therapy. There is a need of updated guidelines to establish clear recommendations in patients on ICIs.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1487-1498"},"PeriodicalIF":3.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Venous Insufficiency: Wound Management. 静脉功能不全：伤口管理。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-10-24 DOI: 10.1007/s11886-024-02140-4

Jordan Blake Iceton, Alex Haro, Judy Lau, Eri Fukaya

引用次数: 0

Innovations in Imaging: ¹⁸F-Fluorodeoxyglucose PET/CT for Assessment of Cardiovascular Infection and Inflammation. 成像技术的创新：18F-氟脱氧葡萄糖 PET/CT 用于评估心血管感染和炎症。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-12-01 Epub Date: 2024-09-24 DOI: 10.1007/s11886-024-02137-z

Siddharth J Trivedi, Jamieson M Bourque

引用次数: 0

Echocardiography for Management of Cardiovascular Disease in Pregnancy. 超声心动图治疗妊娠期心血管疾病。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-09-26 DOI: 10.1007/s11886-024-02126-2

Mary Rodriguez Ziccardi, Joan E Briller

引用次数: 0

Echocardiography in Systemic Lupus Erythematosus. 系统性红斑狼疮的超声心动图。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.1007/s11886-024-02121-7

Mohammed Z Al-Zahir, Kwan-Leung Chan

{"title":"Echocardiography in Systemic Lupus Erythematosus.","authors":"Mohammed Z Al-Zahir, Kwan-Leung Chan","doi":"10.1007/s11886-024-02121-7","DOIUrl":"10.1007/s11886-024-02121-7","url":null,"abstract":"Purpose of review: In patients with systemic lupus erythematosus (SLE), cardiovascular involvement is common and a major cause of morbidity and mortality. There have been few recent updates regarding the cardiac involvement in this clinical entity. The purpose of the review is to provide an update on the role of echocardiography in the management of these patients.Recent findings: Echocardiography remains the imaging modality of choice and should be considered even in asymptomatic patients with SLE to detect cardiac abnormalities which are frequently not clinically apparent. Transesophageal echocardiography has higher sensitivity and specificity in identifying valvular lesions, and should be utilized in high risk patients when transthoracic echocardiography is negative. New advances such as speckle tracking echocardiography has shown promise in the detection of occult myocardial dysfunction, but more studies are needed to have a proper perspective of its role in SLE patients. SLE has protean cardiac manifestations. The most common involvement is pericarditis. Complicated pericarditis such as tamponade and constriction are rare but should be considered if the symptoms do not subside with treatment. Valvular involvement can take several forms. Libman-Sacks endocarditis is the most common form and is more prevalent in patients with high disease activity and with the presence of antisphopholipid antibodies. Myocardial involvement portends poor prognosis and should be sought and treated promptly to prevent morbidity and mortality.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1265-1271"},"PeriodicalIF":3.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Promise and Perils of Transcatheter Aortic Valve Replacement (TAVR) in Low Surgical Risk Patients with Severe Aortic Stenosis in the Current Era. 经导管主动脉瓣置换术 (TAVR) 在当前时代对手术风险低的重度主动脉瓣狭窄患者的承诺与危险。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-16 DOI: 10.1007/s11886-024-02116-4

Ahmed Hassanin, Molly Szerlip

引用次数: 0